Johnson & Johnson ​said on Monday it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging ...

Vanessa Sheppard joins FAMU to lead the pharmacy school and drive research innovation as the university pursues R1 status.

Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), announces that new data from the Phase 3 VISIONARY ...

Ashland Inc. (NYSE: ASH), a global leader in additives and specialty ingredients, today announced the appointments of two new independent members of the Company Board of Directors and the formation of ...

According to Schniepp, inspectors are not auditing the electronic submission mechanism itself because the eCTD system is ...

Gerren McHam, vice president of Government and External Affairs, API Innovation Center, describes how China’s recent export ...

Washington, D.C.- Vice President Raquel Peña and Minister of Public Health Víctor Atallah met Tuesday with U.S. Secretary of ...

The HealthCare Institute of New Jersey has announced the election of new Board of Trustee officers and Steering Committee ...

Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the ...

Johnson & Johnson has set aside $5.5 billion to resolve tens of thousands of US lawsuits alleging that its talcum ...

Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with ...

In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.